GYRE
Gyre Therapeutics Inc.
7.50$
+1.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Gyre Therapeutics Inc. (GYRE) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/01/2026 | Current report (8-K) | GYRE THERAPEUTICS, INC. (GYRE): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/26/2026 | Current report (8-K) | GYRE THERAPEUTICS, INC. (GYRE): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.